Healthy adults
Conditions
Interventions
Subjects will take three tablets of the test food product once daily for 12 weeks.
Subjects will take three tablets of the placebo food product once daily for 12 weeks.
Sponsors
IMEQRD Co. Ltd.
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Age: 20 or over but under 65 (at the time of consent) 2. Gender: Males and females with Japanese nationality 3. Individuals with a BMI of 23.0 kg/m^2 or more but less than 30.0 kg/m^2 4. Ability to input electronic diaries through smartphones or PCs 5. Individuals who after receiving a comprehensive explanation and understanding the study objectives and details voluntarily consented to participate in writing
Exclusion criteria
Exclusion criteria: 1. Those currently receiving medical or herbal treatment for a disease (however, chronic use is permissible) 2. Those currently on diet or exercise therapy under the supervision of a doctor 3. Those with severe diseases, current or past 4. Those with surgical history on the digestive tract (however, appendicitis is acceptable) 5. Those currently consuming quasi-drugs, Foods for Specified Health Use, Foods with Functional Claims, health foods or supplements that may affect obesity, hyperlipidemia, and lipid metabolism 6. Those regularly(nearly 3 times a week or more) consuming quasi-drugs, Foods for Specified Health Use, Foods with Functional Claims, health foods or supplements other than the ones listed above unless they can stop after consent is obtained 7. Those unable to abstain from alcohol the day before the test 8. Those with present or past food or drug allergy 9. Those with excessive drinking habits (approximately 40g or more alcohol consumption a day) 10. Those with heavy smoking habits (approximately 21 or more cigarettes per day) 11. Those with shift work that involves night shifts 12. Those with metal implanted in the body through surgery 13. Those with a heart pacemaker or implanted medical device 14. Those with claustrophobia 15. Those planning to significantly change lifestyle habits (diet, sleep, exercise habits etc.) during this trial period, such as through long-term travel 16. Those currently pregnant or breastfeeding, or wishing to get pregnant during this trial period 17. Those participating in clinical trials of other pharmaceutical products or health foods, or those within 4 weeks of trial completion, or intending to participate in other clinical trials after the consent for this trial 18. Others whom the study physician deem inappropriate as subjects for the trial
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Body fat area (visceral fat area, subcutaneous fat area, total fat area) | — |
Secondary
| Measure | Time frame |
|---|---|
| -Weight, BMI -Body fat percentage -Perimeter of each part of body (waist, hip, thigh, upper arm, neck) -Blood tests (TG, LDL-C, blood glucose level, uric acid, ALT, AST) -Questionnaire evaluation -Anti-glycation -Physical activity monitored via a smartwatch | — |
Countries
Japan
Contacts
Public ContactYoshitada Hira
IMEQRD Co., Ltd Planning and Sales Department
Outcome results
None listed